Joseph Vincent Manetta

Title: Joseph Vincent Manetta: Innovator in Monoclonal Antibodies

Introduction

Joseph Vincent Manetta is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 5 patents, his work has the potential to impact various medical applications.

Latest Patents

Among his latest patents is the invention of Anti-ferroportin 1 monoclonal antibodies and their uses. These monoclonal antibodies and antigen-binding fragments are designed to bind to and inhibit the activity of human FPN1. This innovation is effective in maintaining or increasing the transport of iron out of mammalian cells. Additionally, it helps in maintaining or increasing the levels of serum iron, reticulocyte count, red blood cell count, hemoglobin, and hematocrit in a subject in vivo.

Career Highlights

Joseph Vincent Manetta is currently associated with Eli Lilly and Company, where he continues to advance his research and development efforts. His work is crucial in the ongoing exploration of therapeutic solutions that address iron transport and related health issues.

Collaborations

He collaborates with esteemed colleagues such as John R Sportsman and Donmienne Doen Mun Leung, contributing to a dynamic research environment that fosters innovation.

Conclusion

Joseph Vincent Manetta's contributions to the field of monoclonal antibodies exemplify the impact of innovative research in biotechnology. His work not only enhances our understanding of iron transport but also paves the way for potential therapeutic advancements.